SLC16A7 | Solute carrier family 16 (monocarboxylate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC17A3 | Solute carrier family 17 (organic anion transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC1A4 | Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC22A23 | Solute carrier family 22, member 23 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC24A1 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC26A10 | Solute carrier family 26, member 10 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A5 | Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC34A1 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35A5 | Solute carrier family 35, member A5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35B1 | Solute carrier family 35, member B1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35C2 | Solute carrier family 35 (GDP-fucose transporter), member C2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35F2 | Solute carrier family 35, member F2 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC35F3 | Solute carrier family 35, member F3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35F4 | Solute carrier family 35, member F4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35F6 | Solute carrier family 35, member F6 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC36A4 | Solute carrier family 36 (proton/amino acid symporter), member 4 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC37A4 | Solute carrier family 37 (glucose-6-phosphate transporter), member 4 | Predicted membrane proteins
| | | | | Expressed in all |
SLC38A11 | Solute carrier family 38, member 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC38A7 | Solute carrier family 38, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A9 | Solute carrier family 38, member 9 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A1 | Solute carrier family 41 (magnesium transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC44A3 | Solute carrier family 44, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC44A5 | Solute carrier family 44, member 5 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC4A5 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 5 | Cancer-related genes Predicted membrane proteins
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
SLC5A12 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC6A9 | Solute carrier family 6 (neurotransmitter transporter, glycine), member 9 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC8A2 | Solute carrier family 8 (sodium/calcium exchanger), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC8B1 | Solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC9B2 | Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLCO2B1 | Solute carrier organic anion transporter family, member 2B1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SPNS1 | Spinster homolog 1 (Drosophila) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SPPL2A | Signal peptide peptidase like 2A | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SPPL3 | Signal peptide peptidase like 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
STRA6 | Stimulated by retinoic acid 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TAP1 | Transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TM9SF1 | Transmembrane 9 superfamily member 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TM9SF1 | Transmembrane 9 superfamily member 1 | Predicted membrane proteins
| | | | | Mixed |
TM9SF2 | Transmembrane 9 superfamily member 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |